Mastering Medical Information with AI: A Global Perspective from Recordati Rare Diseases

Medical Information teams play a crucial role in ensuring accurate, up-to-date, and accessible information for healthcare professionals and patients. At Recordati Rare Diseases, Michelle Bridenbaker, Global Head of Medical Information, and her team faced increasing demands across multiple domains: "We have so many different tasks and things that we need to accomplish," Michelle explains. "We needed a partner to help us tackle key areas while augmenting our existing resources."

With a global responsibility for Medical Information, the team required a scalable solution to accelerate content turnaround while maintaining accuracy. While basic Large Language Models (LLMs) showed promise, they lacked the integration and workflow optimization necessary for real-world application.

The Solution: MedPro by AVAYL

Understanding these challenges, AVAYL introduced MedPro, an AI-driven solution designed to enhance medical information workflows. The team at Recordati Rare Diseases saw an opportunity to leverage MedPro’s automation and augmentation capabilities to improve efficiency.

"We started looking at different solutions that required automation or augmentation of our human capabilities," Michelle recalls. "When we started discussing what the AVAYL team was hoping to achieve, it was clear that this would finally put all the pieces of the puzzle together."

Through seamless integrations with industry-standard literature providers such as PubMed, internal content management systems like SharePoint, and third-party literature resources, MedPro became an essential tool for streamlining processes. The AI-driven approach enabled the team to generate, organize, and retrieve medical content more efficiently than ever before.

The Impact: Transforming Medical Information and Beyond

The adoption of MedPro delivered faster content turnaround, ensuring that Recordati Rare Diseases could respond to medical inquiries with greater speed and accuracy. As the collaboration progressed, the team discovered that MedPro’s capabilities extended beyond Medical Information alone.

"What started as an amazing project for medical information, I now see, with all the enhancements and integrations we've achieved together, that this could be a powerful tool for the wider business as well," says Michelle.

Beyond MedInfo, Medical Science Liaisons (MSLs) and Medical Directors also began to recognize MedPro’s potential as a strategic companion, further expanding its impact within the organization.

A True Partnership in AI Innovation

What differentiates AVAYL from other AI providers is its commitment to true partnership and deep industry understanding. Rather than offering an out-of-the-box solution, AVAYL worked closely with Recordati Rare Diseases to tailor MedPro to their specific workflows and needs.

"The difference with AVAYL has been that experience - truly trying to understand what we do on a day-to-day basis and not making that an afterthought. They ask a lot of questions. They’re curious."

For organizations exploring AI-driven medical information solutions, Michelle offers a clear recommendation: "I would always recommend making sure that you invite AVAYL to the table because you will see the difference."